Publication | Closed Access

Effects of the angiotensin receptor blocker, telmisartan, on cardiovascular events in high-risk patients intolerant to ACE-inhibitors. Erratum of Vol 372(9644):1174-83

Molecular PharmacologyHypertensionCardiovascular DiseaseAntihypertensive TherapyVascular PharmacologyPharmacologyCardiovascular PharmacologyVascular BiologyPharmacotherapyAngiotensin Receptor BlockerMedicineHigh-risk PatientsCardiovascular Events